EHS
EHS

Guideline updated for managing hyperbilirubinemia in newborns


In a clinical practice guideline revision issued by the American Academy of Pediatrics and published online Aug. 5 in Pediatrics, updated recommendations are presented for the management of hyperbilirubinemia in newborn infants ≥35 weeks of gestation.

In the updated guidance, Alex R. Kemper, M.D., M.P.H., from the Nationwide Children’s Hospital in Columbus, Ohio, and colleagues note that an infant should have a direct antiglobulin test and the infant’s blood type should be determined as soon as possible if the maternal antibody screen is positive or unknown. Oral supplementation with water or dextrose water is not recommended to prevent hyperbilirubinemia or decrease bilirubin concentrations. At least every 12 hours following until discharge, all should be visually assessed for jaundice. For infants noted to be jaundiced

“Kernicterus is rare, but the impact on children and their families can be devastating,” Kemper said in a statement. “The guideline provides clinicians, birthing centers, and hospitals with strategies to prevent the worst-case scenarios and to help educate families so they recognize the signs of jaundice and know when to follow-up with their pediatrician.”


Most breastfed infants not receiving recommended vitamin D supplementation


More information:
Clinical Practice Guideline Revision

Technical Report

Copyright © 2022 HealthDay. All rights reserved.

Citation:
Guideline updated for managing hyperbilirubinemia in newborns (2022, August 5)
retrieved 6 August 2022
from https://medicalxpress.com/news/2022-08-guideline-hyperbilirubinemia-newborns.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

EHS
Back to top button